“…Fluorinated thiazolidionol (Figure , compound 3 ) can induce AMPK activation and inhibit PI3K/AKT/mTORC1 and MEK/ERK pathways, triggering ADCD in pancreatic ductal adenocarcinoma MIA PaCa-2 and PANC-1 cells proved by increased cytoplasmic vacuoles formation and enhanced autophagic flux . Further, compound 3 can suppress migration, invasion, and angiogenesis of MIA PaCa-2 and PANC-1 cells and regress the development of the MIA PaCa-2 xenograft in a mice model Figure , compound 4 ) induces cytotoxicity that is associated with autophagic machinery and does not relate to the apoptotic pathways, which could trigger ADCD in a variety of types of cancer cells (e.g., A549, HeLa, Hep3B, HepG2, LLC-1, MCF-7, PC3 cells) and apoptosis-defective or -resistant cells (e.g., caspase-3/-7/-8/deficient mice embryonic fibroblasts (MEFs), caspase-3/-7 double knockout (DKO) MEFs and Bax-Bak DKO MEFs) .…”